drugset / Trial / NCT00911261
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if Oxymorphone Extended Release is effective and safe in treating chronic pain in patients with cancer or neuropathic pain.
Timeline
- Start
- 2003-08
- Primary completion
- 2005-03
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxymorphone | Small molecule | 5 mg | — |
| Subject | Oxymorphone | Small molecule | 10 mg | — |
| Subject | Oxymorphone | Small molecule | 20 mg | — |
| Subject | Oxymorphone | Small molecule | 40 mg | — |